<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03991949</url>
  </required_header>
  <id_info>
    <org_study_id>AL35</org_study_id>
    <nct_id>NCT03991949</nct_id>
  </id_info>
  <brief_title>Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula</brief_title>
  <official_title>Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula With Prebiotic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This single-group study will assess growth and tolerance of infants fed a post-discharge
      preterm infant formula containing a prebiotic.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 4, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight</measure>
    <time_frame>SDAY 1 to SDAY 56</time_frame>
    <description>Change in weight-for-age z-score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stool Characteristics</measure>
    <time_frame>Study Day (SDAY) 1 to SDAY 56</time_frame>
    <description>Parent completed diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Formula Intake</measure>
    <time_frame>SDAY 1 to SDAY 56</time_frame>
    <description>Parent completed diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length</measure>
    <time_frame>SDAY 1 to SDAY 56</time_frame>
    <description>Interval length gain per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head Circumference</measure>
    <time_frame>SDAY 1 to SDAY 56</time_frame>
    <description>Interval HC gain per day</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Infant Development</condition>
  <arm_group>
    <arm_group_label>Experimental Infant Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ready-to-feed, milk-based formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Infant Formula</intervention_name>
    <description>Formula fed Ad libitum</description>
    <arm_group_label>Experimental Infant Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age at birth less than 37 weeks

          -  Birth weight less than 3200 g (approximately 7 pounds)

          -  Postmenstrual age is 34 0/7 through 41 0/7 weeks at enrollment

          -  Parent(s) confirm their intention to feed their infant the study product as the sole
             source of nutrition for the duration of the study

          -  The currently-fed formula is a milk-based infant formula at a caloric density of â‰¤ 24
             Cal/fl oz.

          -  Singleton, twin, or triplet births only.

          -  Parent(s) confirm their intention not to administer solid foods or juices to their
             infant from enrollment through the duration of the study, unless instructed otherwise
             by their healthcare professional.

          -  Participant's parent(s) has voluntarily signed and dated an ICF, approved by an
             IRB/IEC and provided HIPAA (or other applicable privacy regulation) authorization
             prior to any participation in the study.

        Exclusion Criteria:

          -  An adverse maternal, fetal or participant medical history that is thought by the
             investigator to have potential for effects on tolerance, growth, and/or development.

          -  Participant is taking and plans to continue taking medications, home remedies, herbal
             preparations, prebiotics or probiotics, rehydration solutions, or parenteral nutrition

          -  Participant is known to require elective surgery with hospitalization, other than
             uncomplicated outpatient surgery, during the course of the study.

          -  Participant is in another study that has not been approved as a concomitant study

          -  Participant has an allergy or intolerance to any ingredient in the study product

          -  Participant is currently receiving oxygen therapy

          -  Participant is currently receiving antibiotics

          -  Participant is currently receiving tube feedings
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>34 Weeks</minimum_age>
    <maximum_age>41 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle Johnson, RDN, LD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RDN, LD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alabama Clinical Therapeutics, LLC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Clinical Research-Deland, LLC; Accel Clinical Research</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32829</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Iowa Stead Family Children's Hospital</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Cleveland Pediatric Research Center, LLC</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Holston Medical Group</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Women's Hospital at Renaissance - Doctors Hospital at Renaissance</name>
      <address>
        <city>Edinburg</city>
        <state>Texas</state>
        <zip>78539</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ventavia Research Group</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 18, 2019</study_first_submitted>
  <study_first_submitted_qc>June 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2019</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

